Objectives: The purpose of this study was to evaluate the diagnostic performance of magnetization transfer (MT) imaging and multigradient echo magnetic resonance imaging (MRI) to quantify pancreatic fibrosis and lipomatosis in patients before pancreatoduodenectomy for postoperative risk stratification with histopathology as the reference standard. Materials and Methods: Twenty-four patients (age, 68 ± 8 years, 16 males) prospectively underwent quantitative MT imaging using a 2-dimensional gradient echo sequence with and without MT prepulse and multigradient echo imaging on a 3 T MRI 1 day before pancreatoduodenectomy due to adenocarcinoma of the pancreatic head region (n = 20), neuroendocrine tumor (n = 3), or intraductal papillary mucinous neoplasm (n = 1). Magnetization transfer ratio (MTR) and proton density fat fraction (PDFF) were measured in pancreatic tail (PT) and at the resection margin (RM). Histopathologically, pancreatic fibrosis was graded as mild, moderate, or severe (F1-F3), lipomatosis was graded as 0% to 10%, 11% to 30%, and greater than 30% fat deposition (L1-L3). In addition, MTR and histopathologic fibrosis was assessed in pancreatic adenocarcinoma. MannWhitney U test and Spearman correlation were used. Results: Patients with advanced pancreatic fibrosis (F3) showed a significantly higher MTR compared with the F1 group at the RM and PT (38 ± 4 vs 32.3 ± 1.6, P = 0.018 and 39.7 ± 5.5 vs 31.2 ± 1.7, P = 0.001). Spearman correlation coefficient of MTR and fibrosis grade was r = 0.532 (P = 0.011) and 0.554 (P = 0.008), respectively. Pancreatic parenchyma with advanced fat deposition (L2-L3) showed significantly higher PDFF compared with lipomatosis grade L1 (RM: P = 0.002 and PT: P = 0.001). Proton density fat fraction of pancreatic parenchyma exhibited a moderate and significant correlation with histopathologic lipomatosis grade (RM: r = 0.668 and PT: r = 0.707, P < 0.001). Magnetization transfer ratio was significantly higher in pancreatic adenocarcinoma compared with pancreatic parenchyma (44 ± 5.5 vs 36.0 ± 4.4 and 37.4 ± 5.4, P = 0.004). Conclusions: Multiparametric MRI of the pancreas including MTR and PDFF maps may provide quantitative and noninvasive information on pancreatic fibrosis and lipomatosis before surgery.
T he only potential curative therapy for pancreatic carcinoma at this time is complete surgical resection, which is still associated with a risk for postoperative complications. [1] [2] [3] Development of postoperative pancreatic fistula is the most relevant complication with a reported incidence of 10% to 25% 2 and often results in morbidity after pancreatic resection. [4] [5] [6] [7] Several factors have been reported to be associated with an increased rate of postoperative pancreatic fistula (POPF), such as pancreatic lipomatosis, absence of fibrosis, and small pancreatic duct size. 4, [8] [9] [10] Fatty infiltration is thought to increase the softness of the gland and therefore increases the risk of developing POPF. 11, 12 Soft pancreas has a high exocrine activity and a poor structure holding capacity leading to technical difficulties with enteropancreatic anastomosis. In opposite, hard pancreatic texture caused by increased fibrosis of the pancreatic tissue is associated with decreased risk of POPF. Fibrotic pancreatic parenchyma has decreased exocrine activity, 9, 11, 13 which decreases the risk of proteolytic destruction of the anastomosis. 9 Another favorable aspect of fibrosis relates to the increased hardness of the pancreatic texture, which better facilitates the enteropancreatic anastomosis.
Preoperative evaluation of pancreatic parenchyma texture as an indicator of postoperative complications would be of interest for risk stratification of patients and may also influence postoperative patient care or choice of surgical technique. Some studies have attempted to predict the risk of POPF with preoperative magnetic resonance imaging (MRI) by assessing signal characteristics and contrast enhancement of the pancreatic parenchyma as surrogate for pancreatic fibrosis and lipomatosis preoperatively. 4, 12, 14, 15 Recently, magnetization transfer (MT) MRI has been described as a method to quantify fibrosis. 16 Magnetization transfer describes the physical process of the exchange of magnetization between free hydrogen nuclei and those bound to macromolecules. 15, 17, 18 The MT effect size depends on the concentrations of these macromolecules, for example, collagen in an aqueous physiological environment, 17 the higher the concentration of macromolecules, the higher the MT effect is. Because the free water proton pool is diminished in a fatty environment, fat deposition in soft tissue environment has a confounding effect on MT ratio (MTR) values. Measured MTR values are reduced in a fatty environment. [17] [18] [19] [20] Previous reports showed MT imaging of the small bowel with sufficient image quality for identification of fibrotic scarring in an animal model and in patients with Crohn disease. 17, 21 Martens et al 22 used MT imaging to assess tumor response after chemoradiotherapy in rectal cancer with promising results and showed that MTR can be used to discriminate postradiation fibrosis from residual tumor in rectal cancer. 23 First applications of MT imaging on the pancreas were reported by Li et al, 24 who evaluated MT for quantification of fibrosis levels in pancreatic ductal adenocarcinoma in mouse xenograft models. 19, 24 To our best knowledge, this study is the first to describe MT imaging of the pancreas to quantify pancreatic parenchymal fibrosis.
The second component influencing pancreatic texture is pancreatic fat deposition, which can be measured with MRI. 25 In one previous study, a moderate relationship of pancreatic fat fraction obtained with a triple echo gradient echo sequence with histologic findings was found. 4 The purpose of this study was to evaluate the diagnostic performance of MT imaging and multigradient echo MRI to quantify pancreatic fibrosis and lipomatosis in patients before pancreatoduodenectomy with histopathology as the reference standard.
MATERIALS AND METHODS

Study Population
The local ethics committee approved this prospective study, and all patients gave written informed consent.
From July 2015 to August 2017, 46 patients were scheduled for pancreatoduodenectomy of a pancreatic head tumor or periampullary tumor and considered for study enrolment. Exclusion criteria were missing informed consent (8 patients) and metallic implants excluding an MR scan (1 patient). Thirty-seven consecutive patients underwent preoperative MR of the pancreas according to the study protocol. Of these 37 patients, 6 patients were excluded because finally no pancreatic resection was performed. Thirty-one patients underwent pancreatoduodenectomy to treat pancreatic, periampullary, or bile duct tumors, and histopathology was assessed for the tumors. In 7 patients, the study-relevant MRI sequences were acquired incompletely. Thus, the remaining 24 patients who had a complete preoperative MR examination and underwent pancreatoduodenectomy were included in this study.
Patients' medical history was assessed (diabetes, prior episodes of pancreatitis, alcohol and nicotine abuses, hypertension, and obesity).
MRI Scan Acquisition
The MR examinations were performed in a 3 T MRI system (Skyra; Siemens Healthcare, Erlangen, Germany) with an 18-channel body array matrix-coil and a built-in 32-channel spine coil. The basic MRI protocol consisted of the following imaging sequences: T2-weighted images coronal and axial, T2-weighted images axial fatsaturated, MR cholangiopancreatography, and noncontrast and dynamic postcontrast T1-weighted axial fat-saturated images. In addition, MT imaging with a 2-dimensional gradient echo sequence and proton density fat fraction (PDFF) mapping with multigradient echo Dixon technique were performed. The off-resonance prepulse of the MT sequence had a Gaussian shape with a frequency offset of 1200 Hz, a maximum effective B1 field of 6.7 μT, a duration of 9984 microseconds, an effective flip angle of 500 degrees, and a bandwidth of 192 Hz. The MRI parameters for the MT sequence and multigradient echo sequence are summarized in Table 1 .
Image Analysis
The MTR quantifies the interaction between the unbound water protons and the macromolecular-bound protons and is defined as
where SI 0 and SI SAT refer to the image intensity without and with the saturation prepulse, respectively, as earlier described by Pazahr et al. 17 Magnetization transfer ratio values were calculated pixelwise and displayed as MTR maps using an in-house computer script written in Matlab (R2014a; 8.3.0.532). Magnetization transfer ratio measurements were performed on the MTR maps in Matlab. Proton density fat fraction maps were generated by the scanner and analyzed using a DICOM viewing software (Myrian1; Intrasense, Paris, France). One radiologist (K.S., 5 years of clinical experience) who was blinded to the histopathologic and clinical findings drew regions of interest (ROIs) on MTR maps and PDFF maps. Regions of interest were drawn in nontumorous pancreatic tissue distally located to the tumor avoiding the pancreatic duct and peripancreatic fat with reference of T2-weighted images. One ROI was drawn at the resection margin (RM), and one ROI was drawn in the pancreatic tail (PT), where pancreatic tissue was best visible on the MTR and PDFF maps (Fig. 1) . The ROI in the PT was chosen, because in a clinical setting MTR and PDFF would be measured preoperatively in the pancreatic parenchyma and the future RM could not be reliably identified. Therefore, alternative measurements could be more easily performed in the future remaining PT. The RM for each case was identified by the radiologist and pathologist in consensus by matching the surgical specimen and MRI scans using anatomical landmarks (eg, pancreatic groove, portal vein, and superior mesenteric vein) for guidance. In cases with adenocarcinoma in the pancreatic head (14 cases of pancreatic ductal adenocarcinoma and 1 case of distal bile duct adenocarcinoma with the main tumor mass in the pancreatic head), an ROI was manually placed in the pancreatic tumor covering as much as possible of the tumor (avoiding tumor margins) on the axial MT slice with the greatest tumor diameter. Magnetization transfer ratio values were determined for the skeletal muscle tissue, subcutaneous fat, and the spleen as a reference.
Histopathologic Analysis
The histopathologic features of the pancreatic surgical specimens were evaluated by 2 experienced pathologists in consensus (B.V., 20 years of experience; D.L., 4 years of experience). The histologic analysis consisted of the evaluation of the pancreatic parenchyma at the RM regarding fibrosis and lipomatosis, and the evaluation of desmoplastic fibrosis in the neoplastic lesion. Hematoxylin and eosin staining and elastic van Gieson staining were performed to grade the amount of fibrosis. Hematoxylin and eosin staining was used to grade the degree of fat deposition. For pancreatic fibrosis previously described grading criteria were applied 26 : F0 = normal pancreatic parenchyma, no fibrotic changes; F1 = mild fibrosis with thickening of periductal fibrous tissue; F2 = moderate fibrosis with marked sclerosis of interlobular septa and no evidence of architectural changes; and F3 = severe fibrosis with detection of architectural destruction. For pancreatic lipomatosis, previously described grading criteria 12 were adapted as follows: L1 = 0% to 10% deposition, L2 = 11% to 30%, and L3 = greater than 30%.
Statistical Analysis
Statistical analyses were performed using a commercially available SPSS software Version 22.0.0.0 (IBM Corporation, Armonk, NY). Descriptive statistics were performed on all data and are expressed as mean ± standard deviation (SD). All data were tested for normality using the Kolmogorov-Smirnoff test. Data were analyzed by using Students t test to compare MTR and PDFF means for the pancreatic tumor, RM, and the PT.
Mann-Whitney U test and analysis of variance (ANOVA) were performed to compare MTR and PDFF means measured in the different histologic fibrosis and lipomatosis groups (F0-F3, L1-L3). Spearman correlation coefficients were obtained for each pair of histologic and MR parameters. Correlation coefficients were interpreted as follows: weak, 0.2; moderate, 0.5; and strong, 0.8. 27 Statistical significance was defined as P < 0.05.
RESULTS
Characteristics of the Study Population
Twenty-four patients (mean age, 68 ± 8 years; range, 41-83 years) including 16 men (68 years; range, 41-83 years) and 8 women (69 years; range, 55-79 years) underwent preoperative MRI and pancreatoduodenectomy for adenocarcinoma of the pancreatic head (n = 14), adenocarcinoma of the ampulla vateri (n = 3), duodenal adenocarcinoma (n = 2), adenocarcinoma of the distal bile ducts involving the pancreatic head (n = 1), neuroendocrine tumor (n = 3), and intraductal papillary mucinous neoplasm (n = 1). One patient showed massive parenchymal atrophy disallowing an ROI placement in the pancreatic parenchyma on MT and PDFF sequences, but was included for measuring the MTR in the pancreatic tumor. One patient showed severe artifacts (breathing motion) in the MT sequence and was excluded from MTR measurements.
In total, 22 patients were included for the MTR measurements and 23 patients were included for the PDFF measurements of the pancreatic parenchyma.
The medical history of the included patients revealed that 6 patients had diabetes mellitus type 2, 2 patients had a prior episode of pancreatitis, 2 patients declared alcohol abuse, 3 patients with nicotine abuse, and 14 patients with hypertension. Neither imaging nor histology correlated with these parameters.
Histopathologic Assessment of Pancreatic Fibrosis and Lipomatosis
Histopathologic analysis of the pancreatic parenchyma at the RM revealed 4 patients with F1 fibrosis (18%), 7 patients with F2 fibrosis (32%), and 11 patients with F3 fibrosis (50%). None of the patients had normal (F0) pancreatic parenchyma. Lipomatosis in the pancreatic parenchyma was graded as L1 in 9 patients (39%), L2 in 11 patients (48%), and L3 in 3 patients (13%).
Quantitative Evaluation of MTR Values in the Reference Structures
In the quantitative evaluation of the 2-dimensional MT sequence, we measured high MTR values in reference tissues known to exhibit high MTR: skeletal muscle tissue (48.5% ± 4.0%; n = 24; the erector spinae muscle) and the spleen (36.1% ± 3.4%; n = 18). In the subcutaneous fat, low MTR values were measured (4.0% ± 3.5%; n = 24).
Preoperative MR Assessment of Pancreatic Fibrosis With Magnetization Transfer
The mean MTR at the RM was 36.0 ± 4.4 (P = 0.004), and the PT was 37.4 ± 5.4 (P = 0.004) and were significantly lower than the mean MTR for the pancreatic tumor (44 ± 5.5, ranged from 32.6 to 53.7; n = 15, all histologic F3) (Fig. 2) . Magnetization transfer ratio values at the RM and PT showed moderate correlation with the fibrosis grade (F1-F3) in the specimens (r = 0.532, P = 0.011 and r = 0.554, P = 0.008, respectively). Magnetization transfer ratio values for the F3 group were significantly higher compared with the F1 group at the RM and PT (38.0 ± 4.0 vs 32.3 ± 1.6, P = 0.018 and 39.7 ± 5.5 vs 31.2 ± 1.7, P = 0.001; Fig. 3 ). Significantly higher MTR values were also found in the F3 group versus F1 + F2 group for measurements at the RM (38.0 ± 4.0 vs 33.9 ± 3.7, P = 0.023) and in the F2 versus F1 group in the PT (37.4 ± 3.7 vs 31.2 ± 1.7, P = 0.014). Analysis of variance showed significant difference for the mean MTR values of F1 versus F3 group at the RM (P = 0.013). Mean MTR values for the fibrosis groups F1 to F3 are summarized in Table 2 .
Preoperative MR Assessment of Pancreatic Lipomatosis With Proton Density Fat Fraction
Measured mean and SD PDFF values for the RM and PT were 10% ± 7.5% and 11.1% ± 8% (n = 23). Measured PDFF values at the RM and PT showed moderate correlation with the lipomatosis grade (L1-L3) in the specimens (r = 0.668, P < 0.001 and r = 0.707, P < 0.001, respectively). Proton density fat fraction values for the L3 group demonstrated significantly higher values compared with the L1 group for the RM and PT (16.2 ± 5.1 versus 4.1 ± 2.8, P = 0.012 and 20.4 ± 6.7 versus 4.8 ± 3.8, P = 0.009). Significantly higher PDFF values were also found for the RM and PT comparing L2 versus L1 (13.1 ± 7.8 vs 4.1 ± 2.8, P = 0.007; 13.6 ± 7.2 vs 4.8 ± 3.8, P = 0.005) (Fig. 4) . Analysis of variance showed significant difference for the mean PDFF values of L1 versus L2 group at the RM and PT (P = 0.009 and P = 0.011, respectively) and for L1 versus L3 (P = 0.017 and P = 0.003, respectively). Mean PDFF values for the lipomatosis groups L1 to L3 are summarized in Table 2 .
Correlation Between MTR and PDFF
Magnetization transfer ratio values did not show a significant correlation with PDFF values as measured at the RM and in the PT (r = −0.038 and r = −0.131, P = 0.867 and P = 0.561, respectively).
No significant correlation was found for the mean MTR values at the RM and the PT and the lipomatosis grade of the specimens (r = 0.135, P = 0.548 and r = −0.61, P = 0.788, respectively). Magnetization transfer ratio values did not vary significantly between different lipomatosis groups (P = 0.276-0.971, Table 3 ).
No significant correlation was found for the mean PDFF values at the RM and the PT and the fibrosis grade of the specimens (r = −0.151, P = 0.493 and r = −0.219, P = 0.316, respectively). Proton density fat fraction values did not vary significantly between different fibrosis groups (P = 0.463-0.989, Table 3 ).
Analysis of variance showed no significant difference for the amount of lipomatosis in the different fibrosis groups and vice versa (RM: P = 0.844 and P = 0.542, respectively; PT: P = 0.724 and P = 0.983, respectively).
DISCUSSION
This study found that advanced pancreatic fibrosis and lipomatosis can be noninvasively quantified with MTR and PDFF MRI. Patients with advanced pancreatic fibrosis or lipomatosis showed significantly higher MTR and PDFF obtained by using MT and multigradient echo MRI. The MR data correlated moderately with histology.
Preoperative quantification of pancreatic fibrosis is of special interest as several studies showed that increased fibrosis of pancreatic tissue is associated with a more secure enteropancreatic anastomosis and less exocrine function. 11, 13 Other investigators used the pancreas-tomuscle signal intensity ratio on fat-suppressed T1-weighted MRI scans as a marker for pancreatic fibrosis and showed significant correlation with histology. 12 Yoon et al 4 also used the pancreas-to-muscle signal intensity ratio to quantify pancreatic fibrosis and showed a moderate relationship with histologic finding as patients with advanced fibrosis had significant lower SI ratios than did patients with mild fibrosis. Signal intensity analysis of pancreatic parenchyma on fat-suppressed T1-weighted images, however, may be altered in abnormal parenchyma owing to pancreatic atrophy, fibrosis, edema, or fat deposition, which can be confounding factors. To overcome this problem, we applied an MRI technique based on MT principle to measure pancreatic fibrosis. Physically, MT is a dynamic process that affects spin diffusion between free water molecules and those bound to macromolecules. 19 Thus, MT MRI generates contrast that is primarily determined by the fraction of large macromolecules (eg, in fibrosis) or phospholipid and cell membranes within the interrogated tissue. 19, 28, 29 As proof of concept, we compared MTR in pancreatic adenocarcinomas, known to exhibit desmoplasia related high-grade fibrosis, with MTR measured in pancreatic parenchyma. We found significantly higher MTR in pancreatic tumor compared with pancreatic parenchyma at the RM and PT. All pancreatic adenocarcinomas showed high-grade desmoplastic fibrosis at histology. This finding is in line with previous studies demonstrating that MT MRI can depict desmoplastic stroma in subcutaneous xenograft mouse tumor models of pancreatic ductal adenocarcinoma and offers the potential of noninvasive quantification of fibrosis levels. 19, 24 Furthermore, the MTR values of the pancreatic parenchyma followed the histologic grades of fibrosis with a moderate correlation as well. Data are mean ± standard deviation. For pancreatic lipomatosis: L1 = 0%-10% deposition, L2 = 11%-30%, and L3 = greater than 30%.
MTR indicates magnetization transfer ratio; PDFF, proton density fat fraction; RM, resection margin; PT, pancreatic tail; F1, mild fibrosis; F2, moderate fibrosis; and F3, severe fibrosis. Data are P values. P < 0.05 indicated a significant difference among the groups. For pancreatic lipomatosis: L1 = 0%-10% deposition, L2 = 11%-30%, and L3 = greater than 30%.
MTR indicates magnetization transfer ratio; PDFF, proton density fat fraction; RM, resection margin; PT, pancreatic tail; F1, mild fibrosis; F2, moderate fibrosis; and F3, severe fibrosis.
The MTR values found for the F1 group at the RM were consistently significantly lower than for the F3 group. Magnetization transfer ratio values in the PT were significantly lower in the F1 group than in the F3 group only in the Mann-Whitney U test (P = 0.018), but not with analysis of variance (marginal P value of 0.05). This discordance could be explained by the fact that the histologic fibrosis grades were determined in the pancreatic parenchyma at the RM and are only estimated fibrosis levels of the PT.
The observed MTR values for reference tissues such as skeletal muscle, splenic parenchyma, or subcutaneous fat were in good agreement to previously reported data. 17, 30, 31 Although pancreatic fibrosis has been shown to have a positive effect on postoperative outcome after pancreatoduodenectomy, a soft texture related to lipomatosis of the pancreatic parenchyma has been established as a risk factor for fistula development.
3,9,10,32 Lipomatosis can be quantified with a chemical shift-based multiecho gradient imaging sequence using the T2* corrected Dixon technique to measure the PDFF. 33 It divides MRI-visible protons bound to fat by all protons in the parenchyma (bound to fat and water). Fat water separation and T2* signal decay correction is performed by acquires multiple images at different echo times. Several studies proved that MRI-PDFF is a robust and reproducible biomarker for the assessment of nonalcoholic fatty liver disease (NAFLD). [33] [34] [35] [36] [37] The research group by Idilman et al 25 applied PDFF to determine pancreatic fat deposition in NAFLD. They report that the mean PDFF values for the pancreatic head, pancreatic body, and PT were 4.6% ± 7.1%, 5.7% ± 6.7%, and 6.6% ± 6.1%, respectively, which is in the same range as the L1 lipomatosis group in our study (mean PDFF values for the RM: 4.1% ± 2.8% and for the PT: 4.8% ± 3.8%). Kühn et al 38 quantified pancreatic fat by PDFF and report similar mean pancreatic fat content not adjusted for potential confounders of pancreatic lipomatosis (ie, body mass index) (head, 4.6%; body, 4.9%; tail, 3.9%; being unequally distributed, P < 0.001). Patel et al 39 observed slightly higher PDFF of the pancreas (8.5%) in patients with NAFLD. In our study, the mean PDFF values of the pancreas for all included patients were higher (RM: 10% ± 7.5% and PT: 11% ± 8%). This difference may be potentially explained by the fact that all of our patients had pancreatic head tumors and had a more advanced age compared with the other studies. 25, 38, 39 Both factors are known to contribute to a higher degree of fatty atrophy of the pancreas. [40] [41] [42] The SDs of the PDFF values in our study were relatively high, which is probably due to the low spatial resolution of the PDFF sequence used in this study (Field of view, 39-45 cm; matrix, 160 Â 140) and pancreatic atrophy of this study population resulting in a slender residual pancreatic parenchyma disallowing the placement of a large ROI.
In a previous study, Yoon et al 4 estimated pancreatic fat fraction at MRI using T2*-corrected Dixon technique and showed moderate correlation with histology. Although they used a 3-dimensional tripleecho gradient-echo sequence, we investigated a multigradient echo sequence with 6 echoes. A reduced number of echoes may compromise the accuracy for R2* estimation and degrade the noise performance of R2* quantification. However, the optimal number of echoes for PDFF estimation is controversial. Most studies have evaluated a prototype sequence with 6 echoes. Levin et al 43 published results showing that using the 3 or 4 earliest echoes might be of similar or higher accuracy. Zand et al 44 suggest using 3 to 6 echoes to achieve the highest accuracy for hepatic PDFF estimation. A study by Hernando et al 45 propose a minimum number of echoes for robust R2* estimation of 6. Regarding PDFF estimation of the pancreas, so far no data exist comparing the accuracy of 3 or 6 echo techniques. Similar to Yoon et al, 4 we found a moderate correlation of PDFF measurements in the pancreatic parenchyma and histologic grades of lipomatosis. The multigradient echo sequence used in this study does not only accurately quantify pancreatic lipomatosis but would also correct for T2*-decay pronounced in iron deposition in the pancreas. 46 Magnetization transfer in theory would be decreased in the presence of excessive iron overload, but not in limited iron overload. 47 Iron deposition in the pancreas is mainly described in hemochromatosis or thalassemia major. Because we did not have any patients with increased risk of pancreatic iron deposition in our study population, we did not expect any relevant iron deposition in the pancreas. However, in cases of unknown iron deposition, the multigradient echo sequence would correct for the T2*-decay.
In this study, we found no differences in PDFF of the pancreas among patients with different grades of fibrosis. This somehow contradicts the results reported by Yoon et al 4 who found significantly higher fat fractions in patients with advanced fibrosis compared with without or mild fibrosis. However, our PDFF results are accompanied by histopathologic findings, in which no significant differences in grade of lipomatosis were detected between the different fibrosis groups.
Fat deposition in soft tissue environment has a confounding effect on MTR values. 17, 18, 20, 48 The MT effect grows with the number of hydrogen nuclei that switch from a high-mobility environment, such as in a free water molecule, to a low-mobility environment, such as, for example, in a hydroxyl group bound to a macromolecule. 17 The free water proton pool is diminished in a fatty environment and therefore the measured MTR are reduced. Several fat suppression techniques have been applied to remove the fat component from the MT images. 20, 49, 50 However, fat-suppression and water-or fat-selective pulses may cause additional MT effects and/or alter the steady state of MT sequences. 48 Because the measured PDFF values in this study correlate well with histopathologic grading of the pancreatic lipomatosis, it can be assumed that the applied chemical shift-based multiecho gradient imaging sequence for fat quantification actually measures the fat deposition in the pancreas. Also the MTR measurements in the subcutaneous fat show good agreement with published data with MTR close to zero. 51 Therefore, the applied 2-dimensional gradient echo sequence for fibrosis quantification renders correct quantitative values of MTR in pancreatic tissue also in the case of pancreatic lipomatosis. However, it seems that the lipomatosis of the pancreas in this study population was not pronounced enough to have a reverse effect on the MTR values.
Because of the small patient number, we were not able to adjust our results for patient age. Because patient age is beside fatty atrophy of the pancreas, a risk factor for postoperative pancreatic complications, it should be tested in future and larger studies whether age and level of pancreatic fat as measured by PDFF are independent risk factors.
Our study had also certain limitations. The size of the study cohort and accordingly the subgroups was rather small. Thus, our results should be considered preliminary and require confirmation by studies with larger sample size. Therefore, we performed a retrospective power analysis for comparison of 2 independent means (Student sample t test) with continuous values using an alpha of 0.05 and a 2-tailed test. Clinically, a differentiation between high and low to intermediate pancreatic fibrosis (ie, F3 vs F1 + F2) would be of interest for preoperative risk stratification. Magnetization transfer ratio in the PT for F3 (n = 11) in this study was 39.7 ± 5.5 and for F1 + F2 (n = 11) was 34.3 ± 2.7, resulting in a power of 0.847. The same holds true for the differentiation of high to intermediate and low grades of lipomatosis in the PT (ie, L3 + L2 vs L1, respectively). Proton density fat fraction for L3 + L2 (n = 14) in this study was 17 ± 7 and for L1 (n = 9) was 4.8 ± 3.8, resulting in a power of 0.91.
Because patients with normal pancreas or without suspicion of a pancreatic tumor do not undergo biopsy or surgery, they could not be included in this study and are therefore underrepresented. However, it was still feasible to differentiate pancreatic low-grade from high-grade fibrosis with MTR. The clinical impact of high-grade fibrosis as measured with MTR on postoperative patient outcome was not part of this study, because we first aimed to evaluate the diagnostic performance of MT imaging. Future studies with a larger patient cohort should focus on prediction of postoperative patient outcome based on MT measurements of pancreatic fibrosis. Because of the small patient number, we were not able to adjust our results for patient age. Because patient age is beside fatty atrophy of the pancreas a risk factor for postoperative pancreatic complications, it should be tested in future and larger studies whether age and level of pancreatic fat as measured by PDFF are independent risk factors. In addition, patients included in the study presented a variety of pancreatic tumors such as adenocarcinomas as the largest subgroup as well as intraductal papillary mucinous neoplasm and neuroendocrine tumors. Different pancreatic cancer etiologies may have also different effects on the composition of residual pancreatic parenchyma. Because we obtained all data with the same MR scanner, studies including multiple imagers from various vendors are warranted. Regarding different field strength, MTR values vary only slightly between 1.5 T and 3.0 T. 52 Finally, the current study was performed with ROI-based measurements that encompassed the pancreatic tissue within one slice for both MRI and histology measurements. This associated with challenges in coregistration of histology slides to corresponding in vivo MRI measurements. The imprecision associated with this manual analysis along with the significant difference between MRI slice thickness (millimeter) and histology tissue slice thickness (micrometer) may have been a key source for the variability between MRI and histologic measurements.
In conclusion, multiparameteric MRI of the pancreas including MTR and PDFF maps may provide noninvasive information to quantify pancreatic fibrosis and lipomatosis before pancreatic surgery. Further studies are needed to investigate whether MTR and PDFF may serve as an imaging marker to noninvasively estimate the risk of postoperative complications associated with pancreatic fibrosis and lipomatosis.
